Qiagen

Qiagen is a prominent multinational life sciences and molecular diagnostics firm established in 1984. The company specializes in developing advanced technologies that enable researchers and clinicians to extract meaningful biological insights from samples containing DNA, RNA, and proteins. By providing a comprehensive portfolio of sample preparation, assay technologies, and bioinformatics tools, Qiagen streamlines complex workflows for molecular testing, clinical diagnostics, and scientific research across global markets.

With a workforce of 5,000-10,000 employees, the organization maintains a robust operational footprint across 19 locations worldwide. Qiagen’s technical infrastructure supports high-throughput genomic analysis, next-generation sequencing (NGS) target enrichment, and human identification (HID) procedures. Their solutions are critical for precision medicine, forensic testing, and personalized healthcare, ensuring that laboratories can achieve high levels of standardization and actionable insights from diverse biological samples. The company reports annual revenue of approximately $2.1B, reflecting its significant market presence.

The company’s commitment to innovation is reflected in its extensive catalog of purification technologies, workstations, and clinical decision support software. These tools address the evolving needs of the pharmaceutical and healthcare sectors, facilitating advancements in applied sciences. Meet Qiagen's team to learn more about the leadership and expertise driving these technological developments. Qiagen continues to leverage its deep expertise in molecular technology to deliver reliable, scalable solutions that empower scientific discovery and improve patient outcomes in clinical settings globally.